title: Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancer.
authors.affiliation: University Hospitals Leuven, Leuven, Belgium.
authors.forename: Ignace
authors.initials: I
authors.lastname: Vergote
authors.forename: Claes G
authors.initials: CG
authors.lastname: Tropé
authors.forename: Frédéric
authors.initials: F
authors.lastname: Amant
authors.forename: Tom
authors.initials: T
authors.lastname: Ehlen
authors.forename: Nick S
authors.initials: NS
authors.lastname: Reed
authors.forename: Antonio
authors.initials: A
authors.lastname: Casado
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D020360:Neoadjuvant Therapy / Q000379:methods*; D010051:Ovarian Neoplasms / Q000473:pathology* / Q000601:surgery*